Multi-antigenic alphavirus replicon particles and methods

Details for Australian Patent Application No. 2003297039 (hide)

Owner Alphavax, Inc.

Inventors Caley, Ian; Smith, Jonathan F.; Kamrud, Kurt; Dryga, Sergey

Agent Wrays

Pub. Number AU-B-2003297039

PCT Number PCT/US2003/0397

PCT Pub. Number WO2004/055166

Priority 60/433,058 13.12.02 US; 60/433,299 13.12.02 US

Filing date 12 December 2003

Wipo publication date 9 July 2004

Acceptance publication date 5 March 2009

International Classifications

C12N 7/04 (2006.01) Viruses, e.g. bacteriophages - Inactivation or attenuation

C12N 15/86 (2006.01) Mutation or genetic engineering - Viral vectors

A61K 48/00 (2006.01) Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/433,058 13.12.02 US; 60/433,299 13.12.02 US

19 August 2004 Application Open to Public Inspection

  Published as AU-B-2003297039

5 March 2009 Application Accepted

  Published as AU-B-2003297039

2 July 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297040-Non-directional transmitting from a wireless data base station having a smart antenna system

2003297038-REPLICATION OF HEPATITIS C VIRUS IN NON-HEPATIC EPITHELIAL AND MOUSE HEPATIC CELLS